The expression changes of HSPB1, KRT14, and SFN were further validated using animal models.<h4>Conclusion</h4>This study systematically identified HSPB1, KRT14, and SFN as potential biomarkers for patients with DN. Here, HSPB1 is linked to liver dysplastic nodule.